{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:55:14Z","timestamp":1786978514903,"version":"build-2736575974"},"reference-count":50,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CPT Pharmacom &amp; Syst Pharma"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breastfeeding is important in childhood development, and medications are often necessary for lactating individuals, yet information on the potential risk of infant drug exposure through human milk is limited. Establishing a lactation modeling framework can advance our understanding of this topic and potentiate clinical decision making. We expanded the modeling framework previously developed for sotalol using pregabalin as a second prototypical probe compound with similar absorption, distribution, metabolism, and elimination (ADME) properties. Adult oral models were developed in PK\u2010Sim\u00ae and used to build a lactation model in MoBi\u00ae to simulate drug transfer into human milk. The adult model was applied to breastfeeding pediatrics (ages 1 to 23\u2009months) and subsequently integrated with the lactation model to simulate infant drug exposure according to age, size, and breastfeeding frequency. Physiologically based pharmacokinetic (PBPK) model simulations captured the data used for verification both in adults and pediatrics. Lactation simulations captured observed milk and plasma data corresponding to doses of 150\u2009mg administered twice daily to lactating individuals, and estimated a relative infant dose (RID) of approximately 7% of the maternal dose. The infant drug exposure simulations showed peak plasma concentrations of 0.44\u2009\u03bcg\/mL occurring within the first 2\u2009weeks of life, followed by gradual decline with age after week four. The modeling framework performs well for this second prototypical drug and warrants expansion to other drugs for further validation. PBPK modeling and simulation approaches together with clinical lactation data could ultimately help inform infant drug exposure risk assessments to guide clinical decision making.<\/jats:p>","DOI":"10.1002\/psp4.13266","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T04:14:32Z","timestamp":1729916072000},"page":"1953-1966","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin"],"prefix":"10.1002","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-2855","authenticated-orcid":false,"given":"Cameron","family":"Humerickhouse","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3667-9003","authenticated-orcid":false,"given":"Michelle","family":"Pressly","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoumeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando Florida USA"},{"name":"Department of Environmental and Global Health, College of Public Health and Health Professions University of Florida  Gainesville Florida USA"},{"name":"Center for Environmental and Human Toxicology University of Florida  Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Guinn","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherbet","family":"Samuels","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elimika","family":"Pfuma Fletcher","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4998-1167","authenticated-orcid":false,"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"issue":"4","key":"e_1_2_11_2_1","first-page":"222","article-title":"The risks of not breastfeeding for mothers and infants","volume":"2","author":"Stuebe A","year":"2009","journal-title":"Rev Obstet Gynecol"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-057989"},{"key":"e_1_2_11_4_1","unstructured":"CDC 2022 breastfeeding report card.Ctr Dis Control Prev.2023. Accessed November 21 2023.https:\/\/www.cdc.gov\/breastfeeding\/data\/reportcard.htm"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.800927"},{"key":"e_1_2_11_6_1","unstructured":"National Center for Health Statistics.Health United States Table\u00a039.2023. Accessed November 21 2023.https:\/\/www.cdc.gov\/nchs\/fastats\/drug\u2010use\u2010therapeutic.htm"},{"key":"e_1_2_11_7_1","unstructured":"CDC's Division of Reproductive Health works to improve mental health among women of reproductive age.2016; (0920)."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.15094"},{"issue":"3","key":"e_1_2_11_9_1","first-page":"273","article-title":"Exploring the knowledge gaps in infant drug exposure from human milk: a clinical pharmacology perspective","volume":"63","author":"Guinn D","year":"2023","journal-title":"J Clin Pharm Ther"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-020-09676-2"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12802"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051469"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111038"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116495"},{"issue":"1","key":"e_1_2_11_15_1","first-page":"S106","article-title":"Informing a comprehensive risk assessment of infant drug exposure from human milk: application of a physiologically based pharmacokinetic lactation model for sotalol","volume":"63","author":"Pressly MA","year":"2023","journal-title":"J Clin Pharm Ther"},{"key":"e_1_2_11_16_1","unstructured":"BETAPACE (sotalol hydrochloride).Highlights or Prescribing Information.2021Accessed November 6 2023.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/019865s022lbl.pdf"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009352087"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0211-4"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S222505"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT270420P24"},{"issue":"6","key":"e_1_2_11_21_1","first-page":"37","article-title":"Development and evaluation of pregabalin capsules using QbD approach","volume":"9","author":"Vasantakumar PK","year":"2017","journal-title":"J Chem Pharm Res"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.4172\/2153-2435.1000287"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12265"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0890334415626148"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12830"},{"key":"e_1_2_11_26_1","unstructured":"PubChem compound summary for CID 5486971 pregabalin. National Center for Biotechnology Information. Accessed November 6 2023.https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Pregabalin"},{"key":"e_1_2_11_27_1","unstructured":"Pregabalin.DrugBank Online. Accessed November 6 2023.https:\/\/go.drugbank.com\/drugs\/DB00230"},{"key":"e_1_2_11_28_1","unstructured":"LYRICA (pregabalin).Highlights or Prescribing Information.2018Accessed November 6 2023.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021446s035 022488s013lbl.pdf"},{"key":"e_1_2_11_29_1","unstructured":"Meyer\u2010WonnayH SchneiderM.Pregabalin composition.2005Accessed November 6 2023.https:\/\/patentimages.storage.googleapis.com\/7b\/e3\/7e\/14b1c211d47d8b\/US20050171203A1.pdf"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2007.09.010"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.10.026"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018866928335"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.082255"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9456-8"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.12.028"},{"key":"e_1_2_11_36_1","unstructured":"Tissue expression of SLC7A5 \u2010 Summary \u2010 The Human Protein Atlas. Accessed November 6 2023.https:\/\/www.proteinatlas.org\/ENSG00000103257\u2010SLC7A5\/tissue"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2532-0"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03932.x"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12318"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22825"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2530"},{"key":"e_1_2_11_42_1","volume-title":"ICRP Publication 89: Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values","year":"2003"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.24055"},{"issue":"6","key":"e_1_2_11_44_1","first-page":"284","article-title":"The correlation of lactating Women's breast size and breast milk production","volume":"59","author":"Chanprapaph P","year":"2007","journal-title":"Siriraj Med J"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008030287"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-23.6.424"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/mcn.12938"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02344-14"},{"key":"e_1_2_11_49_1","unstructured":"Breastfeeding Overview.American Pregnancy Association.2022Accessed April 19 2024.https:\/\/americanpregnancy.org\/healthy\u2010pregnancy\/breastfeeding\/breastfeeding\u2010overview\/"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2020.00059"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000142"}],"container-title":["CPT: Pharmacometrics &amp; Systems Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.13266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T10:43:35Z","timestamp":1732272215000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/psp4.13266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/psp4.13266"],"URL":"https:\/\/doi.org\/10.1002\/psp4.13266","archive":["Portico"],"relation":{},"ISSN":["2163-8306","2163-8306"],"issn-type":[{"value":"2163-8306","type":"print"},{"value":"2163-8306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"2024-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}